Please check your internet connection and try again.
**Drug:** Sompraz HP (likely a typo, assuming Pantoprazole HP)
## Overview
Pantoprazole is a proton pump inhibitor (PPI) that reduces gastric acid production.
## Primary Indications
* Gastroesophageal reflux disease (GERD)
* Healing of erosive esophagitis
* Zollinger-Ellison syndrome
* Treatment of duodenal ulcers
* H. pylori eradication (in combination regimens)
## Adult Dosing
* **GERD/Erosive Esophagitis:** 40 mg once daily. Duration varies by indication (e.g., up to 8 weeks for healing erosive esophagitis).
* **Maintenance of Healing:** 40 mg once daily. May be reduced to 20 mg once daily.
* **Zollinger-Ellison Syndrome:** Starting dose 40 mg twice daily. Doses adjusted based on acid output; can range up to 240 mg daily (divided doses).
* **H. pylori Eradication:** 40 mg twice daily for 7-14 days as part of a triple or quadruple therapy regimen.
## Pediatric Dosing
* **GERD/Erosive Esophagitis:**
* **12 to < 18 years:** 40 mg once daily for up to 8 weeks.
* **5 to < 12 years:** 20 mg once daily for up to 8 weeks.
* **1 month to < 5 years:** 1.25 mg/kg once daily, not to exceed 40 mg daily, for up to 8 weeks.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment. However, caution may be warranted in severe hepatic impairment.
## Contraindications
* Known hypersensitivity to pantoprazole or any component of the formulation.
## Adverse Effects
* **Common:** Headache, diarrhea, nausea, dizziness, abdominal pain, flatulence.
* **Serious:** *Clostridioides difficile*-associated diarrhea, bone fractures (hip, wrist, spine) with long-term use, hypomagnesemia, vitamin B12 deficiency, lupus erythematosus (cutaneous and systemic).
## Key Drug Interactions
* **Drugs requiring gastric acid for absorption:** Ketoconazole, itraconazole, iron salts, ritonavir, and others. Pantoprazole may decrease their absorption.
* **Warfarin:** May increase INR and prothrombin time. Monitor INR closely.
* **Methotrexate:** PPIs may increase methotrexate levels. Consider withholding PPI during methotrexate treatment.
* **CYP2C19 substrates:** Pantoprazole can inhibit CYP2C19, potentially affecting metabolism of drugs like clopidogrel (though clinical significance is debated).
## Monitoring
* Monitor for signs and symptoms of *C. difficile* infection.
* Consider baseline and periodic serum magnesium levels, especially with prolonged use (>1 year) or concomitant diuretic/digoxin use.
* Assess for signs of bone fracture risk.
* Monitor for signs of vitamin B12 deficiency with long-term therapy.
## Clinical Pearls
* Administer pantoprazole oral suspension 30 minutes before a meal.
* Pantoprazole tablets should be swallowed whole and not chewed or crushed.
* Long-term PPI use is associated with potential risks, including fractures, *C. difficile* infection, and hypomagnesemia. Use the lowest effective dose for the shortest duration necessary.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and institutional protocols for the most current and complete drug data before making clinical decisions.
